Migrastatin analogs in the treatment of cancer
US8957056B2 · kind B2 · utility
3Cited by
7References
39Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 25, 2005 |
| Grant date | Feb 17, 2015 |
| Priority date | — |
| Expiry date | Aug 22, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In one aspect, the present invention provides a method for treating colon and/or ovarian cancer in a subject comprising administering to a subject in need thereof a compound of general formula (I): wherein R1-R6, R, -R, Q, Y1, Y2 and n are as defined herein, wherein the compound is present in an amount effective to inhibit colon and/or ovarian tumor metastasis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.